Ken Fisher acquired 55 Thousand Pacific Biosciences of California shares worth $204 Thousand. That's 0.00% of their equity portfolio (932nd largest holding). The first Pacific Biosciences of California trade was made in Q3 2020. Since then Ken Fisher bought shares four more times and sold shares on three occasions. The investor's estimated purchase price is $576 Thousand, resulting in a loss of 65%.
NEW YORK, Feb. 21, 2023 /PRNewswire/ -- Major players in the next-generation sequencing market are Illumina Inc., Thermo Fisher Scientific Inc, BGI Group, Ag...
PR Newswire, about 1 year agoThe global "Immune Repertoire Sequencing Market" report aims to provide a detailed analysis of the factors that influence the global business adoption and se...
OpenPR, over 1 year agoThe Insight Partners announces the research on Global Non-invasive Prenatal Diagnostics Market as it covers the key boundaries required for your Research Nee...
OpenPR, over 2 years agoAccording to The Insight Partners market research study titled NGS- Based RNA- Seq Market to 2027 Global Analysis and Forecasts by Product & Services, Techn...
iCrowdNewswire, almost 3 years ago